Gene: SEC23A
Official Full Name: SEC23 homolog A, COPII coat complex componentprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family. It is part of a protein complex and found in the ribosome-free transitional face of the endoplasmic reticulum (ER) and associated vesicles. This protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The encoded protein is suggested to play a role in the ER-Golgi protein trafficking. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31824 | SEC23A Knockout cell line (HeLa) | Human | SEC23A | 1:3~1:6 | Negative | Online Inquiry |
KO31825 | SEC23A Knockout cell line (HCT 116) | Human | SEC23A | 1:2~1:4 | Negative | Online Inquiry |
KO31826 | SEC23A Knockout cell line (HEK293) | Human | SEC23A | 1:3~1:6 | Negative | Online Inquiry |
KO31827 | SEC23A Knockout cell line (A549) | Human | SEC23A | 1:3~1:4 | Negative | Online Inquiry |
SEC23A Gene Knockout Cell Lines are specialized cell lines engineered to lack the SEC23A gene, which plays a crucial role in the transport of proteins and lipids from the endoplasmic reticulum to the Golgi apparatus. This cell model is invaluable for studying the mechanisms underlying vesicle formation and transport, as well as for elucidating the biological pathways influenced by SEC23A. The knockout function is achieved through advanced CRISPR/Cas9 technology, allowing for precise alterations in the genomic DNA, thus providing a reliable platform for investigating protein trafficking dynamics.
The primary function of SEC23A involves its participation in the COPII vesicular transport system. By disrupting this gene, researchers can observe the consequential alterations in cellular processes, including protein secretion, membrane assembly, and overall cell function. This makes SEC23A knockout cell lines essential for research into diseases associated with misfolded proteins and secretion deficiencies, and for unraveling the intricate details of cellular transport mechanisms.
In both research and clinical settings, SEC23A knockout cell lines offer significant advantages. They serve as a powerful tool for drug discovery, allowing for the evaluation of therapeutic compounds that target protein transport pathways. Additionally, these cell lines facilitate the study of cellular responses to stressors that may induce protein misfolding, making them pivotal in understanding various degenerative diseases.
Compared to alternative models, these knockout cell lines provide a more specific and controlled environment for studying SEC23A's roles without the interference found in non-targeted cells. Their precision and reliability make them a preferred choice for researchers aiming to yield reproducible and insightful results.
For researchers, clinicians, and pharmaceutical companies seeking to gain deeper insights into cellular transport mechanisms and their implications for human health, SEC23A Gene Knockout Cell Lines represent an indispensable resource. Our company, a leader in developing biological research tools, is dedicated to providing high-quality, scientifically validated products that support innovative research and contribute to advancements in biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.